ARCHIVES

Matrisian, Nelson, to lead review of NCI translational research programs.

This article is from The Cancer Letter archive.

Vol. 31 No. 34 | September 23, 2005

Download PDF Visit The Full Archive

Related Articles

Are Cancer Drugs Getting Better? FDA’s Richard Pazdur Says “Yes”

February 14, 2014

Triple-Negative Breast Cancer Increases With Number of Births

March 25, 2011

Tip O’Neill Testifies As Cancer Survivor At Hearing Called To Renew Commitment To ‘War On Cancer’

April 26, 1991

ACS Supports NCI’s Bypass Budget In Resolution

March 20, 1992

Robert Day Advocates NCI Payment for Investigator Salaries

May 7, 1999

FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications

September 4, 2009